Breast Carcinoma in Situ
📧 Sign up to get email alerts when something new happens for Breast Carcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
This is an update on a Phase 3 trial evaluating pembrolizumab (Keytruda) as adjuvant therapy for triple-negative breast cancer, with the stu…